Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size study & Forecast, by Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices) by End Use and Regional Forecasts 2025-2035

Description

The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, valued at USD 21.84 billion in 2024, is poised to expand at a steady CAGR of 4.45% during 2025-2035, underpinned by the escalating global prevalence of cardiovascular diseases, advancements in diagnostic and therapeutic technologies, and the increasing adoption of preventive healthcare measures. These devices-ranging from wearable cardiac monitors and implantable loop recorders to advanced pacemakers and defibrillators-play an indispensable role in diagnosing arrhythmias, monitoring cardiac health, and restoring normal heart rhythm. With aging populations, rising obesity rates, and lifestyle-related risk factors intensifying the global cardiovascular burden, the demand for accurate, real-time cardiac monitoring and effective rhythm management solutions is surging across hospital, ambulatory, and homecare settings.

The rising incidence of cardiac disorders has catalyzed significant investment in next-generation devices that offer greater accuracy, remote monitoring capabilities, and enhanced patient comfort. According to the World Health Organization, cardiovascular diseases remain the leading cause of mortality worldwide, accounting for nearly 17.9 million deaths annually. This alarming figure has prompted healthcare providers and policymakers to intensify early detection efforts and expand access to advanced cardiac care. Furthermore, technological breakthroughs-such as AI-enabled diagnostic algorithms, minimally invasive implantable devices, and Bluetooth-enabled portable monitors-are revolutionizing the patient experience, enabling clinicians to track and respond to cardiac events with unprecedented speed and precision. While high device costs and reimbursement challenges in certain regions may temper growth, the expanding scope of telecardiology and integration of cardiac devices into broader digital health ecosystems present promising avenues for market expansion.

From a geographical perspective, North America currently dominates the market, bolstered by robust healthcare infrastructure, a high prevalence of heart disease, and strong adoption of advanced cardiac care technologies. The U.S. leads the region with a mature ecosystem of medical device manufacturers, favorable reimbursement frameworks, and a strong culture of preventive healthcare. Europe follows closely, supported by government-backed screening programs, rising geriatric populations, and a strong regulatory environment ensuring device efficacy and safety. Meanwhile, the Asia Pacific region is expected to register the fastest growth through 2035, fueled by rapid urbanization, growing healthcare investments, and increasing cardiovascular disease awareness in countries such as China and India. This growth is further amplified by improving access to healthcare, strategic collaborations between global device manufacturers and local healthcare providers, and the discovery of underserved patient segments in emerging economies.

Major market players included in this report are:

Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
GE Healthcare
Philips Healthcare
Biotronik SE & Co. KG
Nihon Kohden Corporation
Zoll Medical Corporation
Schiller AG
LivaNova PLC
Asahi Kasei Corporation
Hillrom (Baxter International Inc.)
Lepu Medical Technology Co., Ltd.
MicroPort Scientific Corporation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product:

Cardiac Monitoring Devices
Cardiac Rhythm Management Devices

By End Use:

Hospitals
Ambulatory Care Centers
Homecare Settings

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Forces Analysis

3.1. Market Forces Shaping The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of cardiovascular diseases and aging population increasing demand for monitoring and rhythm management solutions
- 3.2.2. Technological advancements - AI-enabled diagnostics, remote monitoring and minimally invasive implantables enhancing clinical adoption
3.3. Restraints
- 3.3.1. High device costs and reimbursement challenges limiting adoption in price-sensitive markets
- 3.3.2. Regulatory complexity and data privacy/security concerns impeding rapid roll-out of connected devices
3.4. Opportunities
- 3.4.1. Expansion of telecardiology and remote patient monitoring platforms creating new service-based revenue streams
- 3.4.2. Growth in emerging Asia Pacific markets driven by increasing healthcare investment and expanding access to cardiac care

Chapter 4. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecasts by Product 2025-2035

5.1. Market Overview
5.2. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Performance - Potential Analysis (2025)
5.3. Cardiac Monitoring Devices
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Cardiac Rhythm Management Devices
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecasts by End Use 2025-2035

6.1. Market Overview
6.2. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Performance - Potential Analysis (2025)
6.3. Hospitals
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Ambulatory Care Centers
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Homecare Settings
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecasts by Region 2025-2035

7.1. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market
- 7.3.1. U.S. Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.3.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.1.2. End use breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.3.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.2.2. End use breakdown size & forecasts, 2025-2035
7.4. Europe Cardiac Monitoring & Cardiac Rhythm Management Devices Market
- 7.4.1. UK Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.4.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.1.2. End use breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.4.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.2.2. End use breakdown size & forecasts, 2025-2035
- 7.4.3. France Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.4.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.3.2. End use breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.4.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.4.2. End use breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.4.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.5.2. End use breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.4.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.6.2. End use breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Cardiac Monitoring & Cardiac Rhythm Management Devices Market
- 7.5.1. China Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.5.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.1.2. End use breakdown size & forecasts, 2025-2035
- 7.5.2. India Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.5.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.2.2. End use breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.5.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.3.2. End use breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.5.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.4.2. End use breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.5.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.5.2. End use breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.5.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.6.2. End use breakdown size & forecasts, 2025-2035
7.6. Latin America Cardiac Monitoring & Cardiac Rhythm Management Devices Market
- 7.6.1. Brazil Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.6.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.1.2. End use breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.6.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.2.2. End use breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Cardiac Monitoring & Cardiac Rhythm Management Devices Market
- 7.7.1. UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.7.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.1.2. End use breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.7.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.2.2. End use breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Cardiac Monitoring & Cardiac Rhythm Management Devices Market
  - 7.7.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.3.2. End use breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Medtronic plc
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Abbott Laboratories
8.4. Boston Scientific Corporation
8.5. GE Healthcare
8.6. Philips Healthcare
8.7. Biotronik SE & Co. KG
8.8. Nihon Kohden Corporation
8.9. Zoll Medical Corporation
8.10. Schiller AG
8.11. LivaNova PLC
8.12. Asahi Kasei Corporation
8.13. Hillrom (Baxter International Inc.)
8.14. Lepu Medical Technology Co., Ltd.
8.15. MicroPort Scientific Corporation
8.16. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.